publicFounded 2013
Twist Bioscience
Funding Summary
Total Funding
$900M+
Latest Valuation
~$2B (public market cap, Apr 2026)
About
Leading synthetic DNA manufacturer using a proprietary silicon-based platform for high-throughput, low-cost gene synthesis. Critical infrastructure for the entire synbio ecosystem.
platform Programs
Recent Developments
Recent developments are auto-populated from tagged articles in the Newsfeed. Browse all news →